NAAA
UTHR icon

New Age Alpha Advisors’s United Therapeutics UTHR Stock Holding History

New Age Alpha Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Sell
6,267
-124
-2% -$69.8K 0.14% 185
2026
Q1 		$3.79M Sell
6,391
-154
-2% -$76.7K 0.18% 169
2025
Q4 		$3.19M Sell
6,545
-2,673
-29% -$1.24M 0.14% 213
2025
Q3 		$3.86M Sell
9,218
-289
-3% -$97.2K 0.16% 167
2025
Q2 		$2.73M Buy
9,507
+345
+4% +$103K 0.12% 249
2025
Q1 		$2.82M Buy
9,162
+4,525
+98% +$1.55M 0.13% 243
2024
Q4 		$1.64M Buy
+4,637
New +$1.7M 0.07% 361

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

New Age Alpha Advisors's UTHR Position: Q2 2026 in Review

New Age Alpha Advisors reduced its United Therapeutics (UTHR) stake by 1.9% in Q2 2026, selling an estimated $69.8K and leaving 6,267 shares worth $3.4M. The position accounts for 0.14% of the portfolio, ranked #185.

New Age Alpha Advisors first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.86M in Q3 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • New Age Alpha Advisors held 6,267 shares of United Therapeutics worth $3.4M as of Q2 2026.
  • New Age Alpha Advisors sold 124 United Therapeutics shares in Q2 2026, an estimated $69.8K.
  • United Therapeutics made up 0.14% of New Age Alpha Advisors's portfolio in Q2 2026, its #185 holding.
  • New Age Alpha Advisors first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • New Age Alpha Advisors's United Therapeutics position peaked at $3.86M in Q3 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.